BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10863976)

  • 1. CD34+ cells derived from fetal liver contained a high proportion of immature megakaryocytic progenitor cells.
    Ma DC; Sun YH; Zuo W; Chang KZ; Chu JJ; Liu YG
    Eur J Haematol; 2000 May; 64(5):304-14. PubMed ID: 10863976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in cyclin expression during proliferation and differentiation of CD34(+) cells derived from fetal liver induced by thrombopoietin].
    Ma DC; Jin BQ; Sun YH; Chang KZ; Dai B; Chu JJ; Liu YG
    Sheng Li Xue Bao; 2001 Aug; 53(4):296-302. PubMed ID: 11930209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
    Murray LJ; Luens KM; Estrada MF; Bruno E; Hoffman R; Cohen RL; Ashby MA; Vadhan-Raj S
    Exp Hematol; 1998 Mar; 26(3):207-16. PubMed ID: 9502616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization.
    Ma D; Sun Y; Lin D; Wang H; Dai B; Zhang X; Ouyang W; Jian J; Jia W; Xu X; Jin B
    Eur J Haematol; 2005 Mar; 74(3):228-40. PubMed ID: 15693793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and qualitative differences in thrombopoietin-dependent hematopoietic progenitor development between cord blood and bone marrow.
    Mwamtemi HH; Higuchi T; Sawai N; Hidaka E; Koike K
    Transplantation; 2000 Apr; 69(8):1645-54. PubMed ID: 10836376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children.
    van den Oudenrijn S; von dem Borne AE; de Haas M
    Exp Hematol; 2000 Sep; 28(9):1054-61. PubMed ID: 11008018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
    Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
    Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.
    Mattia G; Vulcano F; Milazzo L; Barca A; Macioce G; Giampaolo A; Hassan HJ
    Blood; 2002 Feb; 99(3):888-97. PubMed ID: 11806991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.
    De Bruyn C; Delforge A; Martiat P; Bron D
    Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
    Proulx C; Boyer L; Hurnanen DR; Lemieux R
    J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells.
    Halle P; Rouzier C; Kanold J; Boiret N; Rapatel C; Mareynat G; Tchirkov A; Berger M; Travade P; Bonhomme J; Deméocq F
    Ann Hematol; 2000 Jan; 79(1):13-9. PubMed ID: 10663616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differences in megakaryocyte progenitor ex vivo expansion between CD34+ cells derived from human umbilical cord blood and bone marrow].
    He Y; Meng HX; Zhang YG; Hou SF; Wang H; Huang Y; Li Q; Han JL; Qiu LG; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1398-402. PubMed ID: 19099652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes.
    Schattner M; Lefebvre P; Mingolelli SS; Goolsby CL; Rademaker A; White JG; Foster D; Green D; Cohen I
    Stem Cells; 1996 Mar; 14(2):207-14. PubMed ID: 8991540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
    Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
    Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3.
    Dolzhanskiy A; Basch RS; Karpatkin S
    Blood; 1997 Jan; 89(2):426-34. PubMed ID: 9002944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood.
    Schipper LF; Brand A; Reniers NC; Melief CJ; Willemze R; Fibbe WE
    Br J Haematol; 1998 Jun; 101(3):425-35. PubMed ID: 9633882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors.
    Li K; Yang M; Lam AC; Yau FW; Yuen PM
    Cell Transplant; 2000; 9(1):125-31. PubMed ID: 10784074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.
    Panuganti S; Schlinker AC; Lindholm PF; Papoutsakis ET; Miller WM
    Tissue Eng Part A; 2013 Apr; 19(7-8):998-1014. PubMed ID: 23190353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells.
    Murray LJ; Mandich D; Bruno E; DiGiusto RK; Fu WC; Sutherland DR; Hoffman R; Tsukamoto A
    Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.